X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (88) 88
animals (83) 83
biochemistry & molecular biology (72) 72
phosphorylation (71) 71
cell biology (68) 68
akt/pkb (50) 50
pkb (49) 49
proto-oncogene proteins c-akt - metabolism (46) 46
akt (45) 45
apoptosis (45) 45
signal transduction (44) 44
mice (36) 36
proteins (36) 36
activation (34) 34
kinases (34) 34
oncology (33) 33
phosphatidylinositol 3-kinases - metabolism (30) 30
cancer (29) 29
insulin (29) 29
proto-oncogene proteins c-akt (28) 28
proto-oncogene proteins - metabolism (24) 24
protein-serine-threonine kinases - metabolism (23) 23
enzyme activation (22) 22
expression (22) 22
pi3k (22) 22
pkb/akt (22) 22
phosphatidylinositol 3-kinase (21) 21
protein kinases (20) 20
rats (20) 20
protein kinase b (18) 18
research (18) 18
cell line, tumor (17) 17
male (17) 17
survival (17) 17
biophysics (16) 16
growth (16) 16
pathway (16) 16
protein-kinase-b (16) 16
cell survival (15) 15
female (15) 15
proto-oncogene proteins c-akt - antagonists & inhibitors (15) 15
proto-oncogene proteins c-akt - genetics (15) 15
akt protein (14) 14
biology (14) 14
cells, cultured (14) 14
glycogen-synthase kinase-3 (14) 14
mtor (14) 14
mutation (14) 14
cell line (13) 13
genetics & heredity (13) 13
protein-kinase (13) 13
protein-serine-threonine kinases (13) 13
signal transduction - physiology (13) 13
apoptosis - drug effects (12) 12
genetic aspects (12) 12
identification (12) 12
models, biological (12) 12
3-phosphoinositide-dependent protein kinases (11) 11
blotting, western (11) 11
enzyme inhibitors - pharmacology (11) 11
inhibition (11) 11
life sciences (11) 11
phosphatidylinositol 3-kinases - antagonists & inhibitors (11) 11
physiological aspects (11) 11
protein binding (11) 11
signal transduction - drug effects (11) 11
binding sites (10) 10
cell cycle (10) 10
cells (10) 10
gene expression (10) 10
gene-expression (10) 10
pkb, protein kinase b (10) 10
protein kinase inhibitors - pharmacology (10) 10
transfection (10) 10
analysis (9) 9
biochemistry (9) 9
in-vitro (9) 9
inhibitors (9) 9
insulin - pharmacology (9) 9
kinase (9) 9
pharmacology & pharmacy (9) 9
phosphoinositide 3-kinase (9) 9
pleckstrin homology domain (9) 9
protein-serine-threonine kinases - physiology (9) 9
research article (9) 9
reverse transcriptase polymerase chain reaction (9) 9
signaling pathway (9) 9
crystal-structure (8) 8
diabetes (8) 8
enzyme activation - drug effects (8) 8
in-vivo (8) 8
insulin - metabolism (8) 8
mammalian target (8) 8
metabolism (8) 8
neoplasms - pathology (8) 8
neurosciences (8) 8
oxidative stress (8) 8
protein kinases - metabolism (8) 8
protein-serine-threonine kinases - genetics (8) 8
activated protein-kinase (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical journal, ISSN 1470-8728, 2007, Volume 408, Issue 3, pp. 297 - 315
The specificities of 65 compounds reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases... 
Drug discovery | Kinase profiling | Protein kinase | Anti-cancer drugs | Inhibitor specificity | RHO-ASSOCIATED KINASE | TUMOR PROGRESSION | FAMILY-MEMBERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-PROLIFERATION | protein kinase | P38 MAP KINASE | CYCLIN-DEPENDENT KINASES | RECEPTOR TYROSINE KINASES | drug discovery | kinase profiling | SB 203580 | anti-cancer drugs | ISOFORMS IN-VITRO | P90 RSK | inhibitor specificity | Amino Acid Sequence | Cell Line | Phosphorylation | Recombinant Proteins - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Humans | Drug Design | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Mitogen-Activated Protein Kinases - metabolism | Spodoptera | Yes1, Yamaguchi sarcoma viral oncogene homologue 1 | CSK, C-terminal Src kinase | Lck, lymphocyte cell-specific protein-tyrosine kinase | EGF, epidermal growth factor | FGF-R, fibroblast-growth-factor receptor | PAK, p21-activated protein kinase | PDK, 3-phosphoinositide-dependent protein kinase | PI3K, phosphatidylinositol (phosphoinositide) 3-kinase | NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase | RSK, p90 ribosomal S6 kinase | HEK-293 cells, human embryonic kidney-293 cells | VEGF, vascular endothelial growth factor (vasoendothelial growth factor) | EF2K, elongation-factor-2 kinase | CK, casein kinase | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | ATM, ataxia telangiectasia mutated | SRPK, serine-arginine protein kinase | IL-1, interleukin 1 | MNK, MAPK-integrating protein kinase | ROCK, Rho-dependent protein kinase | CaMKK, CaMK kinase | GST, glutathione transferase | MKK1, MAPK kinase-1 (also called MEK1, MAPK or ERK kinase 1) | GAK, cyclin G-associated kinase | FMK, fluoromethylketone | MST, mammalian homologue Ste20-like kinase | PKA, cAMP-dependent protein kinase | FKBP, FK506-binding protein | PPAR, peroxisome-proliferator-activated receptor | IKK, inhibitory κB kinase | PH, pleckstrin homology | MBP, myelin basic protein | AICAR, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | MAPKAP-K, MAPK-activated protein kinase | Sf21, Spodoptera frugiperda (fall armyworm) 21 | MARK, microtubule-affinity-regulating kinase | PIM, provirus integration site for Moloney murine leukaemia virus | LPS, lipopolysaccharide | MSK, mitogen- and stress-activated protein kinase | MAPK, mitogen-activated protein kinase | MELK, maternal embryonic leucine-zipper kinase | His6, hexahistidine | CAK, cyclin-dependent kinase-activating kinase | Eph-A2, Ephrin A2 receptor | PLK, polo-like kinase | ATF2, activating transcription factor 2 | PKD, protein kinase D | Src, sarcoma kinase | AMPK, AMP-activated protein kinase | MMS, methyl methanesulfonate | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | TORC1, mTOR (mammalian target of rapamycin)–raptor (regulatory associated protein of mTOR) complex | BRSK, brain-specific kinase | RIP2, receptor-interacting protein 2 | IGF-1, insulin-like growth factor-1 | S6K1, S6 kinase 1 | DYRK, dual-specificity tyrosine-phosphorylated and -regulated kinase | HIPK, homeodomain-interacting protein kinase | ZMP, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate | PRAK, p38-regulated activated kinase | PKC, protein kinase C | Src-I1, Src inhibitor 1 | TANK, TRAF (tumour-necrosis-factor-receptor-associated factor)-family-member-associated nuclear factor κB activator | NFAT, nuclear factor for activated T-cells | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | CaMK, calmodulin-dependent kinase | CDK, cyclin-dependent protein kinase | NDRG, N-myc downstream-regulated gene | SmMLCK, smooth-muscle myosin light-chain kinase | TBK1, TANK-binding kinase 1 | PRK, protein kinase C-related kinase | SGK, serum- and glucocorticoid-induced kinase
Journal Article
FEBS letters, ISSN 0014-5793, 2001, Volume 496, Issue 1, pp. 44 - 48
The specificity of 4,5,6,7-tetrabromo-2-azabenzimidazole (TBB), an ATP/GTP competitive inhibitor of protein kinase casein kinase-2 (CK2... 
Casein kinase | Inhibitor | Casein kinase-2 | Protein phosphorylation | Protein kinase | nCK, native casein kinase | OA, okadaic acid | PRAK, p38-regulated/activated kinase | CSK, C-terminal Src kinase | AMPK, AMP-activated protein kinase | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | MAPKAP, MAPK-activated protein kinase | p70S6K, p70 ribosomal protein S6 kinase | CK, casein kinase | SAPK, stress-activated protein kinase | PDK, 3-phosphoinositide-dependent kinase | ROCK, Rho-dependent protein kinase | CDK, cyclin-dependent kinase | G-CK, Golgi casein kinase | PKC, protein kinase C | MKK, MAPK kinase (also called MEK) | PKA, cAMP-dependent protein kinase | DRB, 1-(β-D-ribofuranosyl)-5,6-dichlorobenzimidazole | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | rCK, recombinant casein kinase | ERK, extracellular signal-regulated kinase | HS1, hematopoietic lineage cell-specific protein 1 | MSK, mitogen- and stress-activated protein kinase | TBB, 4,5,6,7-tetrabromo-2-azabenzimidazole or 4,5,6,7-tetrabromobenzotriazole | MAPK, mitogen-activated protein kinase | SGK, serum- and glucocorticoid-induced kinase | CATALYTIC SUBUNIT | ZEA-MAYS | TYROSINE KINASE | CRYSTAL-STRUCTURE | COMPETITIVE INHIBITOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | protein phosphorylation | IMMUNOPHILIN FPR3 | SACCHAROMYCES-CEREVISIAE | protein kinase | CELL BIOLOGY | casein kinase | BIOPHYSICS | inhibitor | CELL-CYCLE | BETA-SUBUNIT | casein kinase-2 | MAMMARY-GLAND | Protein Kinases - metabolism | Jurkat Cells - cytology | Protein Kinases - drug effects | Casein Kinase II | Emodin - pharmacology | Jurkat Cells - metabolism | Humans | Enzyme Inhibitors - pharmacology | Protein-Serine-Threonine Kinases - genetics | Substrate Specificity | Adenosine Triphosphate | Binding Sites - genetics | Binding, Competitive - drug effects | Triazoles - pharmacology | Triazoles - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Binding Sites - drug effects | Protein-Serine-Threonine Kinases - metabolism | Staurosporine - pharmacology | Amino Acid Substitution | Jurkat Cells - drug effects
Journal Article
2003, Volume 546, Issue 1, 5
Book Review
Current Opinion in Pharmacology, ISSN 1471-4892, 2011, Volume 11, Issue 4, pp. 360 - 364
Journal Article
Oncogene, ISSN 1476-5594, 2007, Volume 26, Issue 38, pp. 5606 - 5614
The mechanisms of cell transformation mediated by the nucleophosmin (NPM)/anaplastic lymphoma kinase (ALK... 
Mammalian target of rapamycin (mTOR) | Protein kinase B (PKB/Akt) | Mitogen-activated protein kinase pathway (MAPK) | Anaplastic lymphoma kinase (ALK) | MAMMALIAN TARGET | BIOCHEMISTRY & MOLECULAR BIOLOGY | anaplastic lymphoma kinase (ALK) | mammalian target of rapamycin (mTOR) | T-CELL LYMPHOMA | ANAPLASTIC LYMPHOMA | CELL BIOLOGY | mitogen-activated protein kinase pathway (MAPK) | IN-VITRO | ONCOLOGY | AMINO-ACIDS | GENETICS & HEREDITY | TRANSFORMED B-LYMPHOCYTES | NON-HODGKINS-LYMPHOMA | TUBEROUS SCLEROSIS | S6 KINASE | protein kinase B (PKB/Akt) | MEDIATED LYMPHOMAGENESIS | Immunohistochemistry | Protein Kinases - metabolism | RNA, Small Interfering - genetics | Protein Kinases - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Extracellular Signal-Regulated MAP Kinases - genetics | Proto-Oncogene Proteins c-akt - genetics | Lymphoma, T-Cell - metabolism | Protein-Tyrosine Kinases - genetics | Transfection | Phosphatidylinositol 3-Kinases - pharmacology | Nuclear Proteins - genetics | Proto-Oncogene Proteins c-akt - metabolism | Cell Line | Cell Survival - drug effects | Nuclear Proteins - metabolism | Lymphoma, T-Cell - genetics | Receptor Protein-Tyrosine Kinases | Sirolimus - pharmacology | Blotting, Western | Phosphatidylinositol 3-Kinases - genetics | Protein Kinase Inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Signal Transduction - drug effects | Models, Biological | Lymphoma, T-Cell - pathology | Cell Line, Tumor | Mitogen-Activated Protein Kinases - genetics | Cell Proliferation - drug effects | TOR Serine-Threonine Kinases | Quinazolines - pharmacology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Mitogen-Activated Protein Kinases - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Physiological aspects | Cellular signal transduction | Genetic aspects | Rapamycin | Dosage and administration | Research | Protein kinases | Proteins | Signal transduction | Genetics | Lymphomas | Inhibitor drugs |